159 related articles for article (PubMed ID: 26408644)
21. Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis.
Nakamura T; Kataoka K; Fukuda M; Nako H; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):544-51. PubMed ID: 19581502
[TBL] [Abstract][Full Text] [Related]
22. Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.
Jia N; Dong P; Ye Y; Qian C; Dai Q
Cardiovasc Ther; 2012 Apr; 30(2):117-23. PubMed ID: 20973927
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update.
Vandemark C; Nguyen J; Zhao ZQ
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771035
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotective effect of valsartan in mice with short-term high-salt diet by regulating cardiac aquaporin 1 and angiogenic factor expression.
Jiang Y; Wang HY; Zheng S; Mu SQ; Ma MN; Xie X; Zhang YY; Zhang CX; Cai JH
Cardiovasc Pathol; 2015; 24(4):224-9. PubMed ID: 25659450
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.
Wang L; Li YL; Zhang CC; Cui W; Wang X; Xia Y; Du J; Li HH
Cardiovasc Res; 2014 Mar; 101(3):383-92. PubMed ID: 24259498
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist.
Namekawa J; Nemoto S; Sunada G; Takanashi Y; Fujio S; Shirai M; Asai F
J Vet Med Sci; 2018 Oct; 80(10):1515-1523. PubMed ID: 30175725
[TBL] [Abstract][Full Text] [Related]
28. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
29. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion.
Hu C; Dandapat A; Sun L; Marwali MR; Inoue N; Sugawara F; Inoue K; Kawase Y; Jishage K; Suzuki H; Hermonat PL; Sawamura T; Mehta JL
Hypertension; 2008 Sep; 52(3):556-62. PubMed ID: 18645046
[TBL] [Abstract][Full Text] [Related]
30. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
Banks TE; Rajapaksha M; Zhang LH; Bai F; Wang NP; Zhao ZQ
Eur J Pharmacol; 2022 Jul; 927():175048. PubMed ID: 35644422
[TBL] [Abstract][Full Text] [Related]
31. The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy.
Almutairi M; Gopal K; Greenwell AA; Young A; Gill R; Aburasayn H; Al Batran R; Chahade JJ; Gandhi M; Eaton F; Mailloux RJ; Ussher JR
Can J Cardiol; 2021 Jan; 37(1):140-150. PubMed ID: 32640211
[TBL] [Abstract][Full Text] [Related]
32. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.
Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ
Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859
[TBL] [Abstract][Full Text] [Related]
33. Liraglutide reduces body weight by upregulation of adenylate cyclase 3.
Li Z; Liang Y; Xia N; Lai Y; Pan H; Zhou S; Jiang F; He Y
Nutr Diabetes; 2017 May; 7(5):e265. PubMed ID: 28481334
[TBL] [Abstract][Full Text] [Related]
34. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
35. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution.
Zhao L; Zhu C; Lu M; Chen C; Nie X; Abudukerimu B; Zhang K; Ning Z; Chen Y; Cheng J; Xia F; Wang N; Jensen MD; Lu Y
J Endocrinol; 2019 Feb; 240(2):271-286. PubMed ID: 30530905
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
37. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.
Shiraki A; Oyama J; Komoda H; Asaka M; Komatsu A; Sakuma M; Kodama K; Sakamoto Y; Kotooka N; Hirase T; Node K
Atherosclerosis; 2012 Apr; 221(2):375-82. PubMed ID: 22284365
[TBL] [Abstract][Full Text] [Related]
38. Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis.
Shimojo N; Hashizume R; Kanayama K; Hara M; Suzuki Y; Nishioka T; Hiroe M; Yoshida T; Imanaka-Yoshida K
Hypertension; 2015 Oct; 66(4):757-66. PubMed ID: 26238448
[TBL] [Abstract][Full Text] [Related]
39. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
Kudo H; Kai H; Kajimoto H; Koga M; Takayama N; Mori T; Ikeda A; Yasuoka S; Anegawa T; Mifune H; Kato S; Hirooka Y; Imaizumi T
Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.
Trial J; Heredia CP; Taffet GE; Entman ML; Cieslik KA
Basic Res Cardiol; 2017 Jul; 112(4):34. PubMed ID: 28478479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
